Almirid-Cripar®

Product description

The active substance in Almirid-Cripar is the hydrogenated ergot alkaloid a-dihy­droergocryptine methane sulfonate, which has high affinity for dopamine receptors. alpha-Dihydroergocryptine methane sulfonate is a selective D2 receptor agonist and a partial D1 receptor agonist, and in vivo it has no activity on serotonergic or adre­nergic receptors.

Indication

For the treatment of shaking palsy (idiopathic Parkinson’s disease) in patients without fluctuations in their clinical picture, either as monotherapy or in combination with levodopa (with or without a decarboxylase inhibitor).

Browse by keywords

Acne Antiparkinsonian agent Athlete’s foot Atrophic vaginitis Bacterial vaginosis Dandruff Dermal infections Dopamine agonist Fragile nails Fungal Genital tract Immunostimulant Lamellar splitting Menopause Nail alterations Nail protection Onychomycosis Perineum elasticity childbirth Recurrent and acute respiratory infections Rosacea Skin rejuvenation Urinary tract Vaginal dryness Vaginal pH Vulvo-vaginal infections Yeast infections